TNDM
Tandem Diabetes Care, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website andemdiabetes.com
- Employees(FY) 2600
- ISIN US8753722037
Performance
+4.66%
1W
+28.85%
1M
-19.21%
3M
-16.16%
6M
+21.4%
YTD
+30.34%
1Y
Profile
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Technical Analysis of TNDM 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-17 19:00
TNDM: What does Argus have to say about TNDM?(Argus Research)
- 2024-12-13 08:42
- 2024-12-10 19:00
TNDM: What does Argus have to say about TNDM?(Argus Research)
- 2024-12-10 09:00
- 2024-12-09 20:00
- 2024-12-06 11:31
- 2024-12-06 08:46
- 2024-12-03 19:00
TNDM: Raising target price to $27.00(Argus Research)
- 2024-11-26 19:00
TNDM: Raising target price to $24.00(Argus Research)
- 2024-11-26 06:59
- 2024-11-21 16:05
- 2024-11-21 03:05
- 2024-11-12 19:00
TNDM: Lowering target price to $25.00(Argus Research)
- 2024-11-08 08:28
- 2024-11-08 06:56
- 2024-11-08 05:08
- 2024-11-07 18:25
Analyst Report: Tandem Diabetes Care, Inc.(Morningstar Research)
- 2024-11-07 07:57
Q3 2024 Tandem Diabetes Care Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-11-07 02:21
- 2024-11-06 18:30
- 2024-11-06 17:25
- 2024-11-06 16:05
- 2024-11-06 08:18
- 2024-11-06 03:05
- 2024-11-05 19:00
TNDM: What does Argus have to say about TNDM?(Argus Research)
- 2024-11-01 10:00
- 2024-10-30 16:05
- 2024-10-30 10:01
- 2024-10-30 04:05
- 2024-10-24 08:20
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.